➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Colorcon
Johnson and Johnson
Moodys
Dow

Last Updated: September 21, 2020

DrugPatentWatch Database Preview

Biologic Drugs With Mechanism of Action: Interleukin-5 Antagonists

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Biologic Drugs With Mechanism of Action: Interleukin-5 Antagonists

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Glaxosmithkline Llc NUCALA mepolizumab INJECTABLE;SUBCUTANEOUS LYOPHILIZED POWER 125526 001 2015-11-04   Start Trial Knopp Biosciences LLC (Pittsburgh, PA) 2033-08-13 RX Orphan search
Glaxosmithkline Llc NUCALA mepolizumab INJECTABLE;SUBCUTANEOUS LYOPHILIZED POWER 125526 001 2015-11-04   Start Trial DS BIOPHARMA LIMITED (Dublin, IE) 2035-05-13 RX Orphan search
Glaxosmithkline Llc NUCALA mepolizumab INJECTABLE;SUBCUTANEOUS LYOPHILIZED POWER 125526 001 2015-11-04   Start Trial CureVac AG (Tubingen, DE) 2032-02-15 RX Orphan search
Glaxosmithkline Llc NUCALA mepolizumab INJECTABLE;SUBCUTANEOUS LYOPHILIZED POWER 125526 001 2015-11-04   Start Trial Knopp Biosciences LLC (Pittsburgh, PA) 2033-08-13 RX Orphan search
Glaxosmithkline Llc NUCALA mepolizumab INJECTABLE;SUBCUTANEOUS LYOPHILIZED POWER 125526 001 2015-11-04   Start Trial Patheon Softgels, Inc. (High Point, NC) 2035-06-15 RX Orphan search
Glaxosmithkline Llc NUCALA mepolizumab INJECTABLE;SUBCUTANEOUS LYOPHILIZED POWER 125526 001 2015-11-04   Start Trial PRAIRIE PHARMACEUTICALS LLC (Bethesda, MD) 2030-02-08 RX Orphan search
Glaxosmithkline Llc NUCALA mepolizumab INJECTABLE;SUBCUTANEOUS LYOPHILIZED POWER 125526 001 2015-11-04   Start Trial UBE INDUSTRIES, LTD. (Yamaguchi, JP) 2036-04-28 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Johnson and Johnson
Colorcon
AstraZeneca
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.